Nyheder om menneskers sundhed | HIPRA

who we are

Nyheder om menneskers sundhed

HIPRA's vaccine against COVID-19, BIMERVAX®, receives EMA's positive opinion

30-03-2023

Menneske

Virksomhed

Bimervax

HIPRA launches a clinical trial to study its Covid-19 vaccine as 4th dose

09-11-2022

Menneske

covid vaccine

HIPRA creates a committee of experts for the Covid-19 vaccine project

13-07-2022

Menneske

Virksomhed

comité expertos

HIPRA starts a Phase III clinical trial of the Covid-19 vaccine with immunocompromised participants

13-06-2022

Menneske

Ensayo vacuna HIPRA

EMA starts rolling review of Covid-19 HIPRA’s vaccine

29-03-2022

Menneske

European Medicines Agency

GoodGut and Vall d'Hebron are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

27-03-2022

Menneske

goodgut news